Integra LifeSciences Corp.
Plainsboro, NJ 08536
New Integra Panta 2 TTC Arthrodesis Nail System for Tibio-talo-calcaneal Fusion of The Ankle Due to Severe Arthritis
Designed to achieve bone healing through appropriate bone fixation and bone compression. 12mm of compression for patients of varying anatomy, instrumentation and implants are designed to achieve fusion of the TTC joint. Carbon fiber targeting and compression device offers surgeons an unobstructed view.
Read More »New Integra Panta 2 TTC Arthrodesis Nail System for Tibio-talo-calcaneal Fusion of The Ankle Due to Severe Arthritis
Designed to achieve bone healing through appropriate bone fixation and bone compression. 12mm of compression for patients of varying anatomy, instrumentation and implants are designed to achieve fusion of the TTC joint. Carbon fiber targeting and compression device offers surgeons an unobstructed view.
Read More »Latest Integra Titan Reverse Shoulder System-S Features Glenoid Baseplate Design
The Integra® Titan™ Reverse Shoulder System-S (RSS-S) is offered with advanced imaging analysis that improves fit and stability of patients with varying anatomy. The RSS-S comes with independent central screw for immediate fixation of the patient’s bone and porous-coated central post that enables the bone to grow onto the implant.
Read More »Latest Integra Titan Reverse Shoulder System-S Features Glenoid Baseplate Design
The Integra® Titan™ Reverse Shoulder System-S (RSS-S) is offered with advanced imaging analysis that improves fit and stability of patients with varying anatomy. The RSS-S comes with independent central screw for immediate fixation of the patient’s bone and porous-coated central post that enables the bone to grow onto the implant.
Read More »Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT Revision Total Ankle Replacement System. “Integra’s new total ankle revision system is designed to provide surgeons with stable tibial fixation through a narrow, finned tibia....
Read More »Integra-® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT Revision Total Ankle Replacement System. “Integra’s new total ankle revision system is designed to provide surgeons with stable tibial fixation through a narrow, finned tibia....
Read More »Integra LifeSciences Announces Camino® Flex Ventricular Catheter Receives FDA Clearance for Use with MRI Scans
PLAINSBORO, N.J. - Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Camino-® Flex Ventricular Catheter has received clearance from the United States Food and Drug Administration (FDA) for use with magnetic resonance imaging (MRI). The Camino Flex Ventricular Catheter is an advanced, tunneled ventricular catheter that is MR conditional at 1.5 and 3.0 T, with a...
Read More »Integra LifeSciences Announces Camino-® Flex Ventricular Catheter Receives FDA Clearance for Use with MRI Scans
PLAINSBORO, N.J. - Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the CaminoÃ-® Flex Ventricular Catheter has received clearance from the United States Food and Drug Administration (FDA) for use with magnetic resonance imaging (MRI). The Camino Flex Ventricular Catheter is an advanced, tunneled ventricular catheter that is MR conditional at 1.5 and 3.0 T, with a...
Read More »New Integra Panta 2 TTC Arthrodesis Nail System for Tibio-talo-calcaneal Fusion of The Ankle Due to Severe Arthritis
Designed to achieve bone healing through appropriate bone fixation and bone compression. 12mm of compression for patients of varying anatomy, instrumentation and implants are designed to achieve fusion of the TTC joint. Carbon fiber targeting and compression device offers surgeons an unobstructed view.
Read More »New Integra Panta 2 TTC Arthrodesis Nail System for Tibio-talo-calcaneal Fusion of The Ankle Due to Severe Arthritis
Designed to achieve bone healing through appropriate bone fixation and bone compression. 12mm of compression for patients of varying anatomy, instrumentation and implants are designed to achieve fusion of the TTC joint. Carbon fiber targeting and compression device offers surgeons an unobstructed view.
Read More »Latest Integra Titan Reverse Shoulder System-S Features Glenoid Baseplate Design
The Integra® Titan™ Reverse Shoulder System-S (RSS-S) is offered with advanced imaging analysis that improves fit and stability of patients with varying anatomy. The RSS-S comes with independent central screw for immediate fixation of the patient’s bone and porous-coated central post that enables the bone to grow onto the implant.
Read More »Latest Integra Titan Reverse Shoulder System-S Features Glenoid Baseplate Design
The Integra® Titan™ Reverse Shoulder System-S (RSS-S) is offered with advanced imaging analysis that improves fit and stability of patients with varying anatomy. The RSS-S comes with independent central screw for immediate fixation of the patient’s bone and porous-coated central post that enables the bone to grow onto the implant.
Read More »Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT Revision Total Ankle Replacement System. “Integra’s new total ankle revision system is designed to provide surgeons with stable tibial fixation through a narrow, finned tibia....
Read More »Integra-® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT Revision Total Ankle Replacement System. “Integra’s new total ankle revision system is designed to provide surgeons with stable tibial fixation through a narrow, finned tibia....
Read More »Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris®) and Silastic Toe Replacement (Futura(TM)) Product Portfolios from Tornier N.V.
PLAINSBORO, N.J. and AMSTERDAM, The Netherlands - Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris-® and Salto XT™ ankle replacement products and Tornier's Futura™ silastic toe replacement products, for an undisclosed cash payment....
Read More »Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris-®) and Silastic Toe Replacement (Futura(TM)) Product Portfolios from Tornier N.V.
PLAINSBORO, N.J. and AMSTERDAM, The Netherlands - Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto TalarisÃ-® and Salto XT™ ankle replacement products and Tornier's Futura™ silastic toe replacement products, for an undisclosed cash...
Read More »Integra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical
PLAINSBORO, N.J. –- Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced that it has completed the acquisition of all of the outstanding shares of TEI Biosciences Inc. and TEI Medical Inc. ( TEI"). "We are enthusiastic about the strategic fit of these two organizations, and the positive impact TEI has on both top and bottom-line metrics," stated Peter Arduini, Integra's...
Read More »Integra LifeSciences Completes Acquisition of TEI Biosciences and TEI Medical
PLAINSBORO, N.J. –Ã- Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced that it has completed the acquisition of all of the outstanding shares of TEI Biosciences Inc. and TEI Medical Inc. ( TEI"). "We are enthusiastic about the strategic fit of these two organizations, and the positive impact TEI has on both top and bottom-line metrics," stated Peter Arduini, Integra's...
Read More »